XML 43 R33.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Stockholders' Equity (Details) - USD ($)
 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Mar. 29, 2022
Stockholders’ Equity [Line Items]        
Total unrecognized compensation expense $ 299,671      
Weighted average period 2 years 6 months      
Aggregate intrinsic value of stock options, outstanding $ 928,892 $ 26,010    
Aggregate intrinsic value of stock options, exercisable $ 605,520 24,323    
Common stock exercise price per share (in Dollars per share) $ 2.78      
Common stock purchase shares (in Shares) 4,000      
Aggregate fair value of options granted $ 72,240 $ 90,380    
Common stock outstanding       $ 1,750,000
Common stock, treasury shares (in Shares) 641,963   641,963  
2011 Long-Term Incentive Plan [Member]        
Stockholders’ Equity [Line Items]        
Number of shares issued under plan (in Shares) 17,748      
2016 Long-Term Incentive Plan [Member]        
Stockholders’ Equity [Line Items]        
Number of shares issued under plan (in Shares) 1,300,000      
Percentage of incentive stock option 100.00%      
Number of shares available for future issuance (in Shares) 632,257      
Board of Directors [Member]        
Stockholders’ Equity [Line Items]        
Purchase an aggregate of common stock (in Shares) 24,000      
Exercise price (in Dollars per share) $ 2.78